1. Home
  2. Analysis
  3. Carbamazepine
  4. Fibrosis

Carbamazepine and Fibrosis - a phase IV clinical study of FDA data

Summary:

Fibrosis is reported as a side effect among people who take Carbamazepine (carbamazepine), especially for people who are male, 30-39 old, also take Lorazepam, and have Schizoaffective disorder bipolar type.

The phase IV clinical study analyzes which people have Fibrosis when taking Carbamazepine. It is created by eHealthMe based on reports of 43,715 people who have side effects when taking Carbamazepine from the FDA, and is updated regularly.

What is Carbamazepine?

Carbamazepine has active ingredients of carbamazepine. It is often used in epilepsy. eHealthMe is studying from 44,628 Carbamazepine users. Check the latest studies of Carbamazepine.

What is Fibrosis?

Fibrosis (formation of excess fibrous connective tissue in an organ or tissue) is found to be associated with 697 drugs and 682 conditions by eHealthMe. Check the latest studies of Fibrosis.

On Aug, 08, 2026

43,715 people reported to have side effects when taking Carbamazepine.
Among them, 36 people (0.08%) have Fibrosis.

Could Carbamazepine cause Fibrosis?

Among these 36 people:

What is the gender of people who have Fibrosis when taking Carbamazepine? *

  • female: 26.47 %
  • male: 73.53 %

What is the age of people who have Fibrosis when taking Carbamazepine? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 6.45 %
  • 20-29: 9.68 %
  • 30-39: 29.03 %
  • 40-49: 16.13 %
  • 50-59: 22.58 %
  • 60+: 16.13 %

What are other drugs people take besides Carbamazepine? *

  1. Prilosec: 7 people, 19.44%
  2. Propulsid: 7 people, 19.44%
  3. Lorazepam: 7 people, 19.44%
  4. Zithromax: 6 people, 16.67%
  5. Vicodin: 6 people, 16.67%
  6. Prevacid: 6 people, 16.67%
  7. Metoclopramide: 5 people, 13.89%
  8. Tivicay: 5 people, 13.89%
  9. Compazine: 5 people, 13.89%
  10. Truvada: 5 people, 13.89%

What are other side effects people have besides Fibrosis? *

  1. Weakness: 10 people, 27.78%
  2. Penis Pain: 8 people, 22.22%
  3. Suicidal Ideation: 7 people, 19.44%
  4. Diarrhea: 7 people, 19.44%
  5. High Blood Pressure: 7 people, 19.44%
  6. Fever: 6 people, 16.67%
  7. Fall: 6 people, 16.67%
  8. Pancreatitis (inflammation of pancreas): 5 people, 13.89%
  9. Movement - Uncoordinated: 5 people, 13.89%
  10. Drowsiness: 5 people, 13.89%

What are the existing conditions these people have? *

  1. Schizoaffective Disorder Bipolar Type (mental illness featuring schizophrenia and a mood disorder with mania): 6 people, 16.67%
  2. Schizoaffective Disorder (a mental disorder characterized by disordered thought): 4 people, 11.11%
  3. Hiv Infection: 4 people, 11.11%
  4. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 8.33%
  5. Penis Disorder: 1 person, 2.78%

* Approximation only. Some reports may have incomplete information.

Do you take Carbamazepine and have Fibrosis?

- Check whether Fibrosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Carbamazepine:

Fibrosis treatments and more:

How severe was Fibrosis and when was it recovered:

Expand to all the drugs that have ingredients of carbamazepine:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Carbamazepine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fibrosis:

Browse all the conditions that are associated with Fibrosis:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on carbamazepine (the active ingredients of Carbamazepine) and Carbamazepine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.